Prevention of immunotoxin-induced immunogenicity by coadministration with CTLA4Ig enhances antitumor efficacy
Year: 1997
Type: article
Source: The Journal of Immunology
Authors: C B Siegall, H G Haggerty, G L Warner, D Chace, B Mixan, P S Linsley, T Davidson
Institution: Bristol-Myers Squibb (United States)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1625279209
